OPTIMI
Online Predictive Tools for Intervention in Mental Illness (OPTIMI)
| Coordinatore | EVERIS SPAIN SLU
Organization address
address: Avenida Manoteras 52 contact info |
| Nazionalità Coordinatore | Spain [ES] |
| Totale costo | 5˙149˙074 € |
| EC contributo | 3˙760˙598 € |
| Programma | FP7-ICT
Specific Programme "Cooperation": Information and communication technologies |
| Code Call | FP7-ICT-2009-4 |
| Funding Scheme | CP |
| Anno di inizio | 2010 |
| Periodo (anno-mese-giorno) | 2010-01-01 - 2012-12-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
EVERIS SPAIN SLU
Organization address
address: Avenida Manoteras 52 contact info |
ES (MADRID) | coordinator | 0.00 |
| 2 |
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZURICH
Organization address
address: Raemistrasse contact info |
CH (ZUERICH) | participant | 0.00 |
| 3 |
INSTITUT FUR RESPONSE-GENETIK
Organization address
address: C/O PEYER PARTNER - LOWENSTRASSE contact info |
CH (ZURICH) | participant | 0.00 |
| 4 |
Lanzhou University
Organization address
address: Tianshui Nanlu contact info |
CN (Lanzhou) | participant | 0.00 |
| 5 |
MA Systems and Control Limited
Organization address
address: High Street West End contact info |
UK (Southampton) | participant | 0.00 |
| 6 |
ULTRASIS PLC
Organization address
address: NORTHBURGH house Northburgh street contact info |
UK (LONDON) | participant | 0.00 |
| 7 |
UNIVERSITAETSKLINIKUM FREIBURG
Organization address
address: HUGSTETTER STRASSE contact info |
DE (FREIBURG) | participant | 0.00 |
| 8 |
UNIVERSITAT DE VALENCIA
Organization address
address: AVENIDA BLASCO IBANEZ contact info |
ES (VALENCIA) | participant | 0.00 |
| 9 |
UNIVERSITAT JAUME I DE CASTELLON
Organization address
address: AVENIDA VICENT SOS BAYNAT contact info |
ES (CASTELLON DE LA PLANA) | participant | 0.00 |
| 10 |
UNIVERSITAT POLITECNICA DE VALENCIA
Organization address
address: CAMINO DE VERA S/N contact info |
ES (VALENCIA) | participant | 0.00 |
| 11 |
UNIVERSITY OF BRISTOL
Organization address
address: SENATE HOUSE, TYNDALL AVENUE contact info |
UK (BRISTOL) | participant | 0.00 |
| 12 |
XIWRITE SRL
Organization address
address: Via Maffeo Pantaleoni contact info |
IT (FRASCATI) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
Mental health care represents over a third of the cost of health care to all EU nations. However little is being done to develop effective systems for Prevention of the onset of the illnesses or to provide easier Diagnosis with a view to better determine the effects of treatment.nOPTIMI will change this by developing tools to perform Prediction through early identification of the onset of an illness by monitoring poor coping behaviour. It is based on the hypothesis that the central issue and starting point of longer term mental illness depends on the individual's capacity and ability to cope with stress.nOPTIMI will first identify the occurrence of high stress in the individual on a daily basis. Then it will determine the ongoing effect of stress on the individual by studying the behaviour pattern over a longer period. Finally it will also make estimates of the base line changes in the person's state of mind using symptomatic measurements that closely link depression with cognitive, motor and verbal behaviour. We will use wearable and domestic appliances and identification will be based on noting when stress occurs, at a fine time resolution using ECG and Cortisol, and daily using the Electronic Diary. The effects on behaviour will be identified using EEG, Voice analysis, Physical Activity analysis and the Electronic Diary. Finally specific markers of depression will be checked using EEG, Voice analysis and Physical Activity.The smart sensors will be enhanced with a knowledge based rule system to interpret the data and provide a diagnostic tool for both pharmacological and CBT based preventative and intervening treatments. We will then augment two existing CCBT systems to use these tools in real time to optimise the treatment cycle. We will conduct two phases of trials with volunteers who come from high risk situations (such as mothers caring for a disabled child, recession unemployed and critical final examinations) both phases being held in total in 5 countries